Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Discovering a molecule that could interfere with SARS-CoV-2 replication

In this interview, News-Medical speaks to Stepan Nersisyan about his discovery of a molecule that could replicate SARS-CoV-2.

22 Sep 2020

Inhibition of SARS-CoV-2 with antisense oligonucleotides

A part of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA is highly conserved. Researchers have used this as a target for designing antisense oligonucleotide gapmers to cleave the RNA and disrupt virus replication. Their research is published as a preprint on the online server bioRxiv in September 2020.

22 Sep 2020

Children are disproportionally harmed by precautions involved with lockdowns, say experts

Children, who appear at a relatively lower risk from COVID-19, are disproportionally harmed by precautions involved with lockdowns, say Matthew Snape and Russell Viner in a Perspective.

22 Sep 2020

BCG vaccine may offer protection against COVID-19, shows study

While scientists race to develop and test a vaccine effective against SARS-CoV-2, the virus that causes COVID-19, recent studies have indicated that countries with widespread BCG vaccination appear to be weathering the pandemic better than their counterparts.

22 Sep 2020

Cats’ immune system can deal with SARS-CoV-2, shows study

On 8 May 2020, the Institute of Agrifood Research and Technology (IRTA) reported the case of the first cat infected with SARS-CoV-2 in Spain. It was a 4-year-old cat called Negrito, who lived with a family affected by COVID-19, with one case of death.

22 Sep 2020

Social contacts increase again despite coronavirus

At the beginning of the month, 60 percent still restricted themselves in this regard. At the same time, the proportion of people concerned about the impact of the virus on their social relationships fell to 15 percent.

22 Sep 2020

COVID-19 poses a unique threat during hurricane evacuations

The 2020 hurricane season is breaking records with 23 named storms, and more are projected to develop over the next few weeks.

22 Sep 2020

Nanoparticle SARS-CoV-2 model could potentially speed the search for drugs

A team of scientists from the National Center for Advancing Translational Sciences and Naval Research Laboratory in Washington, D.C., has developed a new tool that mimics how SARS-CoV-2 -- the virus that causes COVID-19 -- infects a cell, information that could potentially speed the search for treatments against the disease.

22 Sep 2020

Belief in pandemic conspiracy theories is an obstacle to minimize the spread of COVID-19

Belief in conspiracy theories about the coronavirus pandemic is not only persistent but also is associated with reluctance to accept a COVID-19 vaccine when one becomes available and to engage in behaviors such as mask-wearing that can prevent its spread, according to researchers at the Annenberg Public Policy Center.

22 Sep 2020

Exploring how COVID-19 pandemic trajectory might unfold in the future

Researchers who adapted standard epidemiological models to explore how the COVID-19 pandemic trajectory might unfold in the next five years report diverse scenarios ranging from recurring severe epidemics to elimination.

22 Sep 2020

Impaired cytotoxic T cell response found in in elderly COVID-19 patients

Although people of any age can become infected with SARS-CoV-2, the virus that causes COVID-19, elderly patients face a higher risk of severity and death than younger patients.

22 Sep 2020

Study detects key differences in immune responses of adults and children with COVID-19

The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have milder disease than adults.

22 Sep 2020

Strength, duration of immunity will shape the future trajectory of COVID-19

New research suggests that the impact of natural and vaccine-induced immunity will be key factors in shaping the future trajectory of the global coronavirus pandemic, known as COVID-19.

21 Sep 2020

People with severe dementia are unaware of COVID-19 outbreak, indicates study

The ongoing coronavirus disease 2019 (COVID-19) pandemic has substantially affected patients with dementia and their caregivers.

21 Sep 2020

COVID-19 mitigation efforts significantly decrease influenza activity

The mitigation strategies implemented to curb the spread of COVID-19 appears to reduce the transmission of influenza in the United States, Australia, Chile, and South Africa. These strategies may augment influenza vaccines, especially for high-risk populations during the seasonal influenza transmission.

21 Sep 2020

Screening university students could reduce community COVID-19 burden

Researchers in Canada and the United States report that screening students for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as universities re-open this fall could reduce the burden of coronavirus disease 2019 (COVID-19) in the broader community.

21 Sep 2020

COVID-19 lockdown measures reduced air pollution in Southeast Asia

In an attempt to contain the spread of the disease, many countries worldwide, including Malaysia and other Southeast Asian (SEA) countries, have enforced lockdowns of varying degrees, which has inadvertently caused some positive changes to the environment.

21 Sep 2020

A cost-effective scalable production of SARS-CoV-2 RBD in yeast

A new study by the Argentinian AntiCovid Consortium and published in the preprint server bioRxiv* in September 2020 reports on the successful characterization of the conformation and stability of the SARS-CoV-2 spike protein receptor-binding domain (RBD) in two different cell systems. This may help to accelerate the development of vaccines and neutralizing antibodies.

21 Sep 2020

Research underlines SARS-CoV-2 N-terminal domain of Nsp1 as a potential drug target

A recent study reveals how the non-structural protein 1 (NSP1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) plays a crucial role in inhibiting the host cell protein synthesis but simultaneously facilitating the viral protein synthesis.

21 Sep 2020

Oncology nurses should be routinely tested for SARS-CoV-2, warn researchers

Researchers from the NHS Foundation Trust, University of Cambridge and Cambridge Clinical Laboratories have warned that until a vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) becomes available, antigen and antibody testing should be carried out among oncology nurses as part of routine patient care.

21 Sep 2020